Phase II Study of Nab-Paclitaxel in Refractory Small Bowel Adenocarcinoma and CpG Island Methylator Phenotype (CIMP)-high Colorectal Cancer

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdy221

Related search